Navigating Equipment & Material Transitions in CGT Manufacturing to Maintain High-Quality Treatment

• Managing operational complexity in a mixed ecosystem of bags and vials to maintain workflow, optimize storage, and manage inventory adjustments
• Utilizing equipment and materials for scale-up to ensure each stage of cell culture and therapy differentiation is reliably supported
• Mitigating risks during technology or material transitions to protect product integrity, prevent contamination, and maintain regulatory compliance

Speakers:

Albert Ribickas

Manager, Bloody & Marrow Transplant Laboratory, Clinical Trial & Commercial Product Handling Team

Moffitt Cancer Center